What are the causes of elevated parathyroid hormone (PTH) levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Causes of Elevated Parathyroid Hormone (PTH)

Elevated PTH levels result from either primary hyperparathyroidism (autonomous parathyroid gland overproduction), secondary hyperparathyroidism (appropriate physiologic response to hypocalcemia or other stimuli), tertiary hyperparathyroidism (autonomous PTH secretion after chronic secondary hyperparathyroidism), or spurious laboratory elevation from assay interference.

Primary Hyperparathyroidism (PHPT)

Primary hyperparathyroidism is the most common pathologic cause of elevated PTH and presents with hypercalcemia and inappropriately normal or elevated PTH levels 1, 2.

Etiology of PHPT:

  • Single parathyroid adenoma (most common cause - approximately 80-85% of cases) 2
  • Multiglandular disease (parathyroid hyperplasia)
  • Familial syndromes: Multiple Endocrine Neoplasia (MEN) types 1 and 2A 3
  • Parathyroid carcinoma (rare) 3

Biochemical Pattern:

  • Elevated or inappropriately normal PTH with hypercalcemia
  • Hypophosphatemia
  • Increased or normal urinary calcium excretion 1

Normocalcemic Variant:

A recognized variant exists where PTH is persistently elevated with consistently normal serum calcium, after excluding all causes of secondary hyperparathyroidism 2. This requires careful exclusion of vitamin D deficiency, renal insufficiency, and other secondary causes 1.


Secondary Hyperparathyroidism

Secondary hyperparathyroidism represents an appropriate physiologic response where PTH elevation occurs with normal or low calcium levels 4.

Major Causes:

Chronic Kidney Disease (most common cause):

  • Reduced calcitriol production
  • Phosphate retention
  • Decreased calcium absorption 3, 4

Vitamin D Deficiency:

  • Reduced intestinal calcium absorption
  • Must maintain 25-OH vitamin D >50 nmol/L to exclude this cause 1
  • Requires long-term correction (>6 months) before diagnosing PHPT 1

Gastrointestinal Disorders:

  • Malabsorption syndromes
  • Inflammatory bowel disease
  • Bariatric surgery (induces vitamin-calcium malabsorption) 5, 3

Medications:

  • Loop diuretics (furosemide): Increase urinary calcium excretion; in a 70-kg patient, 40 mg daily furosemide increases PTH by 22.8 pg/mL 6
  • Inadequate calcium supplementation: 500 mg elemental calcium decreases PTH by 8.7 pg/mL 6
  • Proton pump inhibitors: Impair calcium absorption 6

Hereditary Tubulopathies:

  • Dent disease (X-linked recessive, CLCN5 gene mutation)
  • Hereditary hypophosphatemic rickets with hypercalciuria (SLC34A3 gene)
  • Fanconi-Bickel syndrome (Glut 2 transporter variants)
  • These present with hypercalciuria, hypophosphatemia, nephrocalcinosis 5

Tertiary Hyperparathyroidism

Tertiary hyperparathyroidism develops after prolonged secondary hyperparathyroidism, where autonomous PTH secretion persists despite correction of the initial stimulus, resulting in hypercalcemia 4.

Typical Setting:

  • Chronic kidney disease patients, especially post-kidney transplant
  • Hypercalcemia with elevated PTH distinguishes this from secondary hyperparathyroidism 4

Spurious PTH Elevation (Laboratory Interference)

Critical pitfall: PTH can be falsely elevated due to assay interference, which must be considered when PTH levels are discordant with clinical presentation 7, 8.

Mechanisms:

  • Heterophile antibodies: Most common cause of interference 7
  • Macro-PTH complexes: PTH bound to immunoglobulins or other molecules 8
  • Human anti-animal antibodies 7

Recognition:

  • PTH levels unexpectedly high (often >300-700 pg/mL) with normal calcium, phosphate, vitamin D, and renal function 7, 8
  • Diagnostic tests:
    • Polyethylene glycol (PEG) precipitation test: Recovery <10% suggests interference 7
    • Retest on different assay platform (e.g., if elevated on Roche, test on Siemens) 7

Differential Diagnosis Algorithm

Before diagnosing primary hyperparathyroidism, systematically exclude 5, 1:

  1. Vitamin D deficiency: Measure 25-OH vitamin D; supplement to >50 nmol/L for >6 months
  2. Renal insufficiency: Calculate eGFR
  3. Medications: Review thiazides, lithium, loop diuretics, bisphosphonates, denosumab
  4. Malabsorption: History of bariatric surgery, inflammatory bowel disease

Biochemical Patterns:

PTH elevated + Calcium elevated + Urinary calcium elevated:

  • Primary hyperparathyroidism (most likely)

PTH elevated + Calcium elevated + Urinary calcium low (fractional excretion <2%):

  • Familial hypocalciuric hypercalcemia (FHH) - genetic testing indicated 1

PTH elevated + Calcium normal:

  • Secondary hyperparathyroidism (investigate causes above)
  • Normocalcemic PHPT (diagnosis of exclusion) 1

PTH elevated + Calcium low:

  • Severe vitamin D deficiency
  • Chronic kidney disease
  • Malabsorption

Special Diagnostic Tests

When diagnosis remains unclear after standard workup 5, 1:

  • Oral calcium load test (Pak test): Assess calcium and PTH 2 hours after 1 gram oral calcium
  • Cinacalcet test: 60 mg oral, measure calcium and PTH 1 hour later
  • Pro-FHH score: Helps differentiate PHPT from FHH 1

Common Pitfalls

  1. Failing to correct vitamin D deficiency adequately before diagnosing PHPT - requires >6 months of normal levels 1
  2. Not recognizing assay interference when PTH is markedly elevated with otherwise normal biochemistry 7, 8
  3. Missing medication-induced causes, particularly loop diuretics 6
  4. Inadequate assessment of renal function - even mild CKD can cause secondary hyperparathyroidism 5
  5. Not screening for familial syndromes in young patients or those with multiglandular disease 3

References

Research

Primary hyperparathyroidism.

Nature reviews. Disease primers, 2016

Research

Parathyroid Disorders.

American family physician, 2022

Research

Secondary and tertiary hyperparathyroidism.

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry, 2013

Research

Determinants of parathyroid hormone levels in nursing home residents.

Journal of the American Medical Directors Association, 2007

Research

Falsely elevated parathyroid hormone in a patient with osteoporosis: a case report and review.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2024

Research

Truly elevated PTH or Ulysses syndrome?

Endocrinology, diabetes & metabolism case reports, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.